Research News & Features

Health and Life Science

Contact: Suzanne Lindsey, School of Molecular Biosciences, 206/957-7350; jslindsey@adelphia.net

WSU Researcher Takes Aim at Metastatic Cancer


PULLMAN, Wash. -- "Has it spread?"

That has been one of the questions cancer patients most fear to ask-and one their doctors find most difficult to answer. It can be very hard to tell whether cancerous cells have spread from a tumor into other tissues; and once a cancer spreads from its original site, the patient's odds of survival go way down.

Washington State University scientist Suzanne Lindsey is taking aim against metastatic cancer as part of a new biotech company, the Recodagen (reh-KOH-da-jen) Corporation. The company's technology will be based on Lindsey's discovery of a novel class of protein with the potential to allow doctors to diagnose and target invasive cancer cells.

"Current therapies only target the growth of tumors," said Lindsey. "They don't target invasion."

Yet the most lethal cancers are those that metastasize, or leave their original site and invade other tissues. Invasive cancer cells are resistant to most of the therapies now in use, said Lindsey, and until now it has been very difficult to detect cancer cells that are in the process of spreading to new sites. Being able to target invasive cells as well as cells in the original tumor could provide a potent one-two punch against some of the deadliest forms of the disease.


The start-up company is part of the Accelerator Corporation, a privately-held biotechnology investment and development company located in the Eastlake section of Seattle. Lindsey, who is an affiliate associate professor in WSU's School of Molecular Biosciences, joins the Recodagen team as vice president of discovery and will spearhead the company's research efforts.

The key to Lindsey's approach is a protein called MIG-7 (Migration Inducing Gene-7) that she discovered in her lab at WSU. MIG-7 appears on the surface of cancer cells just before they migrate out of a solid tumor and while the cells are migrating and invading new tissues.

That makes MIG-7 a potential diagnostic feature-a reliable indicator of whether a tumor has spread or is getting ready to spread. The protein also could serve as a sort of bull's-eye on migrating cancer cells, giving clinicians a target to aim at as they look for ways to destroy the metastatic cells. Lindsey said she will be working on therapeutic approaches that specifically target cells that have MIG-7.

Lindsey said her work could also lead to the discovery of other potentially useful proteins. She found MIG-7 by taking a closer look at a stretch of DNA that had been dismissed as "junk DNA"- a segment that was previously thought not to code for a protein. Lindsey said the techniques she developed to find and analyze the MIG-7 gene can be applied to finding other important genes that have so far gone undetected.

"We have proprietary methods to identify and characterize such [genes]. With the expertise and backing of Accelerator, we will be able to rapidly demonstrate the proof of concept and develop products that will ultimately benefit human health," she said.

Howard Grimes, vice president for research and dean of the Graduate School at WSU, praised Lindsey's work. "We believe Dr. Lindsey's research has the potential to have a major impact on how cancers are diagnosed and treated in the future. Her technology represents a shift in the gene-expression paradigm and may lead to novel and effective therapeutics in the oncology treatment arena," he said.

"It is fulfilling to be a part of basic science entering the commercial realm and having an impact on human health," he added.

"We are very excited about the possibilities this technology offers and pleased to be able to contribute to the economic development of Washington State and the Puget Sound area," said John Gardner, vice president for Extension and Economic Development at WSU.

About Accelerator Corporation
Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle, Washington, USA. The corporation provides the resources critical to building the next generation of life-enhancing biotechnology companies. These key resources, provided by global life science leaders such as Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, Alexandria Real Estate Equities, Inc., WRF Capital, and the Institute for Systems Biology, include committed capital from top-tier venture capital firms, state-of-the-art facilities, world-class scientific and technical expertise and support, and experienced biotechnology start-up business management and support. For more information, please go to www.acceleratorcorp.com.

Related News

  • Research results in small, quicker, cooler fuel cell

    Moving away from fossil fuels or using them more efficiently is a worldwide challenge. WSU is rising to the challenge in a variety of ways, including fuel cell research. Jeongmin Ahn, assistant professor in the School of Mechanical and Materials Engineering, recently received a $300,000 grant from Korea Fuel Cell Energy. He will use it to develop a small-scale, compact electric power generator that will use a single chamber solid oxide fuel cell.

  • Federal Grant to Probe Overlooked Microbe for Clues to Cancer-causing DNA Damage

    PULLMAN, Wash.—Cynthia Haseltine has a quick and slightly bizarre three-floor elevator speech: “We study this strange little bug that lives in nearly boiling acid and is going to help us understand part of the cause for leukemias and lymphomas.”

  • DNA Analysis Finds Earliest Example of a Domesticated Bird in U.S.

    PULLMAN, Wash.—Washington State University researchers have found one of North America’s earliest examples of domesticated birds by applying modern DNA analysis to some very old turkey droppings. In a paper out today in the “Proceedings of the National Academy of Sciences,” WSU anthropologists say the turkeys raised by people in the Southwest were genetically distinct from previously known domesticated turkeys in Mexico.

  • Focus of grant on heathy food, fitness

    SEATTLE – When the youth of Delridge and White Center’s Food Empowerment Education and Sustainability Team (FEEST) set local foods they’ve prepared on a pre-Thanksgiving table at the Youngstown Cultural Arts Center on Nov. 25, they will have the power of the prestigious W.K. Kellogg Foundation behind them.

  • Art and science blend to make great wine

    When sipping a fine winemaker’s red in front of the fire, it’s easy to appreciate the art that went into that blend. But anyone who has tried to make wine finds him or herself quickly caught up in what amounts to a science project.

  • Test breaks new ground in field of ecological immunology

    PULLMAN - Charles Darwin saw a product of evolution in the beaks of finches. WSU researchers are looking at the same birds’ immune systems to see evolution in action. Jeb Owen, an assistant professor of entomology, and Marisa King, a zoology doctoral candidate, developed a test to see if the finches Darwin studied more than 150 years ago are developing immunities to two exotic parasites, a virus and a nest fly. The test is the first to detect the antibodies a wild bird marshals against specific parasites and has implications for the study of immunology, evolution and conservation.

  • $3.4 million NIH grant: Vet researcher gets competitive MERIT grant

    PULLMAN - Guy H. Palmer, WSU Regent’s professor of pathology and director of WSU’s School for Global Animal Health, has been awarded $3.4 million from the National Institutes of Health (NIH).

  • Aquatics rehabilitation expert to assist Army

    PULLMAN - Bruce Becker, an expert in the use of water therapy to treat injuries and promote well-being, is helping design a program to speed the recovery of wounded U.S. soldiers. Becker is a physician and research professor who directs the National Aquatic & Sports Medicine Institute at WSU. He will share some of the institute’s research findings with U.S. Army doctors and therapists when he visits Fort Lewis, Wash., on Dec. 8 to help launch the Army’s Aquatic Rehabilitation Program.

  • Sport historian scores with writings on hockey

    PULLMAN – The key to research treasure was given to John Chi-Kit Wong when he was a doctoral student. He had planned to write his dissertation on sports organizations of the 1930s. When he contacted the National Hockey League, he got a surprise. The NHL granted him access to its archives of meeting records, letters and contracts.

  • WSU Spokane Clinical Research Team Selected for Two New Diabetes Trials

    SPOKANE, Wash. – Patient recruitment is underway for two diabetes-related clinical trials to be conducted through the College of Pharmacy at Washington State University Spokane. One is sponsored by Duke and Oxford universities, while the other was developed by the Population Health Research Institute in Hamilton, Ontario, Canada, and offered to WSU through the University of Washington. It will develop data on whether the medication Januvia® makes a difference in cardiovascular outcomes in diabetic patients. Funded by Merck Inc., the trial will involve study sites in 33 countries and follow 14,000 patients for at least three years.

  • Eat, Sleep, Stay Warm: How Our Bodies Find the Balance

    PULLMAN, Wash. –A new study led by scientists at Washington State University shows that alternate products of a single gene help control whether an animal sleeps or stays awake, craves food or doesn’t, and maintains its body temperature or plunges deep into hypothermia.

Research News and Features, PO Box 641040, Washington State University 99164-0932, 509-335-3581, Contact Us